These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia. Okten A, Cakir M, Makuloglu M. Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894 [Abstract] [Full Text] [Related]
27. Cross-sectional evaluation of bone metabolism in men. Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD. J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833 [Abstract] [Full Text] [Related]
28. [Changes in blood concentrations of bone-specific biomarkers, osteocalcin and C-telopeptide, in third or higher parity sows after administration of calcium and vitamin D]. Counotte GH, Groenland G, Salden N. Tijdschr Diergeneeskd; 2009 Mar 15; 134(6):230-7. PubMed ID: 19353919 [Abstract] [Full Text] [Related]
30. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study. Wiernikowski JT, Barr RD, Webber C, Guo CY, Wright M, Atkinson SA. J Oncol Pharm Pract; 2005 Jun 15; 11(2):51-6. PubMed ID: 16460605 [Abstract] [Full Text] [Related]
32. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Greer RM, Buntain HM, Potter JM, Wainwright CE, Wong JC, O'Rourke PK, Francis PW, Bell SC, Batch JA. Osteoporos Int; 2003 Jun 15; 14(5):404-11. PubMed ID: 12730764 [Abstract] [Full Text] [Related]
33. Bone mineral metabolism in children with juvenile idiopathic arthritis--preliminary report. Górska A, Urban M, Bartnicka M, Zelazowska-Rutkowska B, Wysocka J. Ortop Traumatol Rehabil; 2008 Jun 15; 10(1):54-62. PubMed ID: 18391906 [Abstract] [Full Text] [Related]
38. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender]. Ambroszkiewicz J, Gajewska J, Laskowska-Klita T. Med Wieku Rozwoj; 2002 Jun 15; 6(3):257-65. PubMed ID: 12637780 [Abstract] [Full Text] [Related]
39. Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Haderslev KV, Jeppesen PB, Hartmann B, Thulesen J, Sorensen HA, Graff J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Staun M, Mortensen PB. Scand J Gastroenterol; 2002 Apr 15; 37(4):392-8. PubMed ID: 11989828 [Abstract] [Full Text] [Related]
40. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF, Geyikli I, Yazgan P, Celik A. Arch Gynecol Obstet; 2006 Jun 15; 274(3):133-7. PubMed ID: 16532321 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]